Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation.
about
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapyDirect and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney TransplantationCytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.Immune profiling and cancer post transplantationγδ T cells confer protection against murine cytomegalovirus (MCMV).Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study IICD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.The invisible arm of immunity in common cancer chemoprevention agents.Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance.Human γδT-cell subsets and their involvement in tumor immunity.Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.Immune response to CMV in solid organ transplant recipients: current concepts and future directions.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection.IL-7 receptor blockade inhibits IL-17-producing γδ cells and suppresses melanoma development.Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance.Donor Vδ1+ γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL.Cytomegalovirus-negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer
P2860
Q26859775-3E6B06F7-A0C2-40AE-9DB3-FC7647F6DC30Q26863724-2087E391-CB91-429F-B1E7-0164BE796BDAQ33562109-14256BCA-29FB-40AC-B39B-4A568A5A8822Q33855566-3BCD34B8-4092-494B-826C-63B33DCB9ACEQ34077023-61912F39-8464-4E81-98B6-F9F447DFA9A9Q34145201-F0CC5122-4335-4EDC-B77A-0DD91A0CB1ECQ34427661-F626A730-C502-4F81-B1E9-48BC459F3850Q34681370-0B61AFEF-428F-4943-A2BB-E96D51230CDEQ35050810-3FFC1A58-B26F-49C6-B3B4-78F0D68C81C8Q35573003-A1A98206-7C36-42FD-8571-344258561DF3Q36348587-1F143398-4D3F-4971-A6CD-0477DAE0AA24Q36849210-4E9B9C35-7B99-49FF-84CD-4D3A5AF96DA6Q37172099-444C381A-6CFB-4CE8-8583-95834FDF9524Q37681825-76E10372-3240-4A52-87CA-BF3372171911Q37714642-7E2C5E92-02B1-441B-9486-23D950237A7AQ37965695-9ED3939F-F1E0-4F0F-90F2-7533E097156AQ38011227-CE55C332-8BB3-42DB-A8A6-FBD28B89E788Q38151057-49CC4BE5-CC40-4271-BE84-7AC1B814727FQ38152686-7CC9D2F7-8910-4386-ABD0-45A1CD3D772EQ38283536-86632BDB-7AF1-4FFF-8D1A-F3111A465B05Q38802522-1087C0A8-410C-4AD8-93C5-74EEAE06EB34Q39016421-BD502763-2D8A-4671-8F36-FEF98FE7B66CQ39160154-5D988E43-2997-420D-B921-CE39CFB501FEQ39176756-1724CC62-8EC7-49A2-A8FF-0E10A842C91BQ39396311-2EB0A733-6799-43E3-8D67-A7DBCCBF65CBQ40104771-15B75E1D-2E74-413B-9E83-E79B94EC6E9BQ41118007-0273BF08-073A-439B-B1F2-F61364502A67Q41306288-B61DAA78-18DD-469B-AF58-63A80088464EQ50226200-D7EFF79A-A926-461D-906C-CFF61143BAB8Q55266341-EC9648A6-159F-4E2B-9D58-850D3984486AQ58484770-D8AB1A45-8425-46EA-A5DB-546FF0E7FBBA
P2860
Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@ast
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@en
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@nl
type
label
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@ast
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@en
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@nl
prefLabel
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@ast
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@en
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@nl
P2093
P2860
P356
P1476
Cytomegalovirus-induced gammad ...... after kidney transplantation.
@en
P2093
Abdellah Jamai
François Siberchicot
Isabelle Garrigue
Jean-François Moreau
Julie Dechanet-Merville
Karin Martin
Lionel Couzi
Nicholas Moore
Omar Hawchar
Pierre Merville
P2860
P304
P356
10.1681/ASN.2008101072
P577
2009-08-27T00:00:00Z